0 Comments for this article

Tags: , , , ,

WHITEHOUSE STATION, NJ (AP) — Federal regulators have decided not to approve a new combination cholesterol drug made by Merck & Co., at least for now.

The drugmaker says the Food and Drug Administration informed the company it will need more data before it can approve the medicine.

The Merck experimental drug combines the company’s cholesterol drug Zetia with a generic version of rival Pfizer Inc.’s Lipitor, which had been the top-selling drug of all time.

Merck says company officials will talk with the FDA to determine the next steps for trying to win approval. Merck says some new data expected later this year may address the FDA’s concerns.

(Copyright 2012 by The Associated Press. All Rights Reserved.)

Comment on this Story

Leave a Reply

Be the First to Comment!


Related News

4 mins ago
0 Comments for this article
Rain blamed for 500,000-gallon wastewater spill
Read More»
4 hours ago
0 Comments for this article
Brunswick Co. offers free well water testing
Read More»
5 hours ago
0 Comments for this article
Brunswick County assessing pest problem post-storm
Read More»